about
Enhanced Sphingomyelinase Activity Contributes to the Apoptotic Capacity of Electronegative Low-Density Lipoprotein.VLDL from Metabolic Syndrome Individuals Enhanced Lipid Accumulation in Atria with Association of Susceptibility to Atrial FibrillationElectronegative low density lipoprotein induces renal apoptosis and fibrosis: STRA6 signaling involved.Chemical composition-oriented receptor selectivity of L5, a naturally occurring atherogenic low-density lipoprotein.Highly electronegative LDL from patients with ST-elevation myocardial infarction triggers platelet activation and aggregationFour Statin Benefit Groups Defined by The 2013 ACC/AHA New Cholesterol Guideline are Characterized by Increased Plasma Level of Electronegative Low-Density Lipoprotein.Genotyping of Chlamydia trachomatis from clinical specimens in Taiwan.The underlying chemistry of electronegative LDL's atherogenicity.Interplay between CRP, Atherogenic LDL, and LOX-1 and Its Potential Role in the Pathogenesis of Atherosclerosis.The role of electronegative low-density lipoprotein in cardiovascular diseases and its therapeutic implications.Comparison of the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 test v1.0 with v2.0 in HIV-1 viral load quantification.The development of a beacon-based real-time PCR for cytomegalovirus and its application in immunocompromised patients.High seroprevalence of human herpesvirus 8 infection in patients with systemic lupus erythematosus.Xanthine-derived KMUP-1 reverses glucotoxicity-activated Kv channels through the cAMP/PKA signaling pathway in rat pancreatic β cells.Electronegative Low-Density Lipoprotein L5 Induces Adipose Tissue Inflammation Associated With Metabolic Syndrome.Rapid Screening for Deleted Form of β-thalassemia by Real-Time Quantitative PCR.Increased expression of suppressor of cytokine signaling 1 mRNA in patients with rheumatoid arthritis.Range of L5 LDL levels in healthy adults and L5's predictive power in patients with hyperlipidemia or coronary artery diseaseAn Updated Review of Lysophosphatidylcholine Metabolism in Human DiseasesFlavonoids from (L.) O. Kuntze seed ameliorates TNF-α induced insulin resistance in HepG2 cellsHuman electronegative LDL induces mitochondrial dysfunction and premature senescence of vascular cells in vivo.Urinary adiponectin as a new diagnostic index for chronic kidney disease due to diabetic nephropathy.Electronegative low-density lipoprotein of patients with metabolic syndrome induces pathogenesis of aorta through disruption of the stimulated by retinoic acid 6 cascadeRole of Ceramidases in Sphingolipid Metabolism and Human DiseasesUltrasensitive ELISA Developed for DiagnosisEfficiency comparison of PGBR extract and γ-oryzanol in antioxidative stress and anti-inflammatory properties against metabolic syndromePre-germinated brown rice extract ameliorates high-fat diet-induced metabolic syndromeImmunoregulatory effects of very low density lipoprotein from healthy individuals and metabolic syndrome patients on glial cellsO-GlcNAcylation disrupts STRA6-retinol signals in kidneys of diabetesVery Low-Density Lipoproteins of Metabolic Syndrome Modulates STIM1, Suppresses Store-Operated Calcium Entry, and Deranges Myofilament Proteins in Atrial MyocytesIdentifying the Therapeutic Significance of Mesenchymal Stem Cells
P50
Q30383521-FCEA2CE3-1953-487D-B4C3-4AF386DAB6CDQ36512701-D64E09C8-5F81-4622-AD66-245CD4BCA0D0Q37123819-C2A4A375-8B67-4D1A-A0EE-1E47DA89F3A5Q37276420-43BB66E4-F101-4C15-B334-07BBB40641C5Q37334725-CE281A01-71EC-425E-A85E-C56ABB499288Q37448634-BD5A0A6F-A882-44AF-9689-1A28674A3B55Q37862911-6AE0AE5C-C7B3-4C9F-8D08-923B74E52BE6Q38217088-7615105D-618F-4B46-B41B-F540F42286B2Q38647831-9C941B15-3A68-44B3-9967-CA252E2B1A60Q39063662-B1EFC43F-1DF8-41AC-9BFB-218C73E7EEC3Q41122403-95596C5E-84AB-4D00-829A-047AB0CA10B9Q41506139-5C713D6C-D435-453A-B837-C0566E083749Q42252634-E3484DC6-CF58-4347-B42C-B1875B2D1783Q47355367-B87A7E70-9D46-44CB-A08D-892A282B6EDEQ47447007-AE544369-5823-4C63-AA76-8E627787F066Q47861448-B1DC0ECF-46A9-42AC-9A45-59769ADD41A2Q54424759-1BAAD7D7-3CBC-47D5-9331-E0A9A722BA65Q58796005-710CD09A-707F-4937-BECA-A12E3B285092Q64057248-FA07B3E5-43BA-47A4-8E91-5889FDA28574Q64236990-195607C4-F44D-456D-BDC5-61B406C5D9ACQ64904140-3A88F4DD-1C96-49C0-A7B6-B5A01D42DDA1Q64993913-5A911D07-4C54-4CD1-ABEA-7E2C9BA50784Q90611906-CB1FB782-5B0C-4BD0-98AC-0560C2C0EC43Q91810355-C48D338F-FCC6-4317-8C58-E36EE8EFCAF3Q92026239-A638B48D-18F4-480D-BFF4-F26648046E41Q92040732-229F7420-5BEF-413C-A0F6-15893320BC04Q92232180-6CA9577D-D4B6-4ABA-AB25-EDE7D93A81BCQ92551290-E6F0C34D-9540-45DE-851B-82B541A79B62Q92579734-1929E01F-541B-4121-BCF8-3622A134470AQ92941380-D3B2FA67-34BC-4FCE-8585-536340774996Q94567010-D0B51601-7180-4A25-BCB0-1714A02F5518
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Liang-Yin Ke
@en
Liang-Yin Ke
@nl
type
label
Liang-Yin Ke
@en
Liang-Yin Ke
@nl
prefLabel
Liang-Yin Ke
@en
Liang-Yin Ke
@nl
P31
P496
0000-0002-2547-0987